The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit

Anesthesia and Analgesia

Volumn 89, Issue 6, 1999, Pages 1360-1365

  Lowson, Stuart M ^a,b   Hassan, Hassan M ^a   Rich, George F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA THROMBOGLOBULIN; METHEMOGLOBIN; NITRIC OXIDE;

ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXYGENATOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0032747216     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199912000-00005     Document Type: Article

References (35)

1. Harker L, Malpass T, Branson H, et al. Mechanisms of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selected α-granule release. Blood 1980;65:323-35.
2. Woodman R, Harker L. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
3. Morse D, Adams D, Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thorac Surg 1988;65:691-5.
4. Ferroni P, Speziale G, Ruvolo G, et al. Platelet activation and cytokine production during hypothermic cardiopulmonary bypass - a possible correlation? Thromb Haemost 1998;80: 58-64.
5. Gemmell C, Ramirez S, Yeo E, Sefton M. Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 1995;125:276-87.
6. Mellgran K, Friberg L, Hedner T, et al. Blood platelet activation and membrane glycoprotein changes during extracorporeal life support (ECLS) - in vitro studies. Int J Artif Organs 1995;18: 315-21.
7. George J, Pickett E, Saucerman S, et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986;78:340-8.
8. Mellion B, Ignarro L, Ohlstein E, et al. Evidence for the inhibitory role of guanosine 3′5′-monophosphate in ADP-induced platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
9. Nguyen B, Saitoh M, Ware A. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991;261:H1043-52.
10. Weber A, Strobach H, Schror K. Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 1993;247:29-37.
11. Radomski M, Palmer R, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987;92:181-7.
12. Radomski M, Palmer R, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
13. Radomski M, Palmer R, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
14. Radomski M, Vallance P, Whitely G, et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993;27:1380-2.
15. De Graaf J, Banga J, Moncada S, et al. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992;85:2284-90.
16. Hogman M, Frostell C, Arnberg H, et al. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994;151:125-9.
17. Kermarrec N, Zunic P, Beloucif S, et al. Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Am J Resp Dis Crit Care 1998;158:833-9.
18. Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664-5.
19. Gries A, Motsch J, Penk S, et al. Sex-dependent differences in bleeding time prolongation under inhaled nitric oxide. Br J Anaesth 1995;74(Suppl A):407.
20. Nong Z, Hoylaerts M, Van Pelt N, et al. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res 1997;81:865-9.
21. Sanama C, Diaby M, Fellahi J, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995;83:56-65.
22. Ferrer R, Masclans J, Angles R, et al. Anticoagulant effects of nitric oxide inhalation in ARDS. Intensive Care Med 1998;24: 837-8.
23. Mellgren K, Friberg L, Mellgren G, et al. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 1996;61:1194-8.
24. Keh D, Gerlach M, Kurer I, et al. Reduction of platelet trapping in membrane oxygenators by transmembranous application of gaseous nitric oxide. Int J Artif Organs 1996;19:291-3.
25. Konishi R, Shimizi R, Firestone L, et al. Nitric oxide prevents human platelet adhesion to fibre membranes in whole blood. ASAIO J 1996;42:M850-3.
26. Sly K, Prager M, Li J, et al. Platelet and neutrophil distributions on pump oxygenator circuits. ASAIO J 1996;42:M494-9.
27. Mellgren K, Mellgren G, Lundin S, et al. Effect of nitric oxide gas on platelets during open heart operations. Ann Thorac Surg 1998;65:1335-41.
28. Rinder C, Bohnert J, Rinder H, et al. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991;75:388-93.
29. Langford E, Parfitt A, de Belder A, et al. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione. Thromb Haemost 1997;78:1516-9.
30. Larsson P, Wallen N, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-7.
31. Hjemdahl P, Larsson P, Wallen N. Effects of stress and beta-blockade on platelet function. Circulation 1991;84(Suppl VI): VI44-61.
32. Ardlie N, McGuiness J, Garrett J. Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis 1985;58:251-9.
33. De Caterina R, Lombardi M, Bernini W, et al. Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentrations and hemodynamic effects. Am Heart J 1990;119:855-62.
34. Schafer A, Alexander R, Handin R. Inhibition of platelet function by organic nitrate vasodilators. Blood 1980;55:649-54.
35. Muikko O, Kuitunen A, Hynynen M. Effects of organic nitrate vasodilators on platelet function before and after cardiopulmonary bypass. Acta Anaesthesiol Scand 1995;39:618-23.